Long-term safety and immunologic outcomes of daily oral immunotherapy for peanut allergy.
The journal of allergy and clinical immunology. Global(2023)
Abstract
Long-term immunomodulation without any new safety signals was reported with PTAH immunotherapy in the largest safety data set and longest treatment duration for oral immunotherapy published to date.
MoreTranslated text
Key words
PTAH,oral immunotherapy,peanut allergy,peanut (Arachis hypogaea) allergen powder,pooled safety,immunologic outcomes
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined